|
| 38078766 | Comparison of <i>Clostridioides difficile</i> nucleic acid amplification test (NAAT) results using fresh and frozen stool specimens and rectal swabs. | J Clin Microbiol | 2024 |
| 36327388 | Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022. | Clin Infect Dis | 2023 |
| 37592963 | Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021. | Antimicrob Steward Healthc Epidemiol | 2023 |
| 37796753 | Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged â¿¥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37478837 | Association between SARS-CoV-2 Symptoms, Ct Values, and Serological Response in Vaccinated and Unvaccinated Healthcare Personnel. | J Appl Lab Med | 2023 |
| 37572864 | The role of microbiome-based therapeutics for the reduction and prevention of antimicrobial-resistant organism colonization. | Anaerobe | 2023 |
| 37771748 | Impact of the Severe acute respiratory syndrome coronavirus 2 pandemic on mortality associated with healthcare-associated infections. | Antimicrob Steward Healthc Epidemiol | 2023 |
| 35580849 | Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States. | Clin Infect Dis | 2023 |
| 37255285 | Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022. | Clin Infect Dis | 2023 |
| 37183993 | Identifying, deconstructing, and deimplementing low-value infection control and prevention interventions. | Infect Control Hosp Epidemiol | 2023 |
| 36987862 | Knowledge, beliefs, and practices related to coronavirus disease 2019 (COVID-19) infection and vaccination in healthcare personnel working at nonacute care facilities. | Infect Control Hosp Epidemiol | 2023 |
| 37381734 | Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patients. | Infect Control Hosp Epidemiol | 2023 |
| 36978404 | Microbiology Clinical Culture Diagnostic Yields and Antimicrobial Resistance Proportions before and during the COVID-19 Pandemic in an Indian Community Hospital and Two US Community Hospitals. | Antibiotics (Basel) | 2023 |
| 37439570 | Intensive care unit sinks are persistently colonized with multidrug resistant bacteria and mobilizable, resistance-conferring plasmids. | mSystems | 2023 |
| 37104244 | Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37301704 | Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022. | Vaccine | 2023 |
| 37263419 | Risk factors for hospital-onset Clostridioides difficile infections before and during the severe acute respiratory syndrome coronavirus 2 pandemic. | Am J Infect Control | 2023 |
| 37260365 | Coronavirus disease 2019 (COVID-19) infection prevention practices that exceed Centers for Disease Control and Prevention (CDC) guidance: Balancing extra caution against impediments to care. | Infect Control Hosp Epidemiol | 2023 |
| 36924218 | Personal protective equipment use among dental healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic and the impact of an educational video in clinical practice. | Infect Control Hosp Epidemiol | 2023 |
| 36883903 | Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants. | J Infect Dis | 2023 |
| 36714284 | Healthcare-associated infections (HAIs) during the coronavirus disease 2019 (COVID-19) pandemic: A time-series analysis. | Antimicrob Steward Healthc Epidemiol | 2023 |
| 36493966 | Risk factors for hospital-acquired infection during the SARS-CoV-2 pandemic. | J Hosp Infect | 2023 |
| 34491341 | Multiplatform Assessment of Saliva for SARS-CoV-2 Molecular Detection in Symptomatic Healthcare Personnel and Patients Presenting to the Emergency Department. | J Appl Lab Med | 2022 |
| 35675695 | Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. | Clin Infect Dis | 2022 |
| 35545083 | Persisting uropathogenic Escherichia coli lineages show signatures of niche-specific within-host adaptation mediated by mobile genetic elements. | Cell Host Microbe | 2022 |
| 35440351 | Comparison of aerosol mitigation strategies and aerosol persistence in dental environments. | Infect Control Hosp Epidemiol | 2022 |
| 35664456 | Antibiotic-resistant organisms establish reservoirs in new hospital built environments and are related to patient blood infection isolates. | Commun Med (Lond) | 2022 |
| 35818721 | Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness. | Influenza Other Respir Viruses | 2022 |
| 35417701 | Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults. | Cell Rep | 2022 |
| 35744803 | Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs. | Molecules | 2022 |
| 35385875 | mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients. | J Infect Dis | 2022 |
| 36447607 | Assessment of Infectious Diseases Risks From Dental Aerosols in Real-World Settings. | Open Forum Infect Dis | 2022 |
| 36695662 | Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022. | Open Forum Infect Dis | 2022 |
| 36580424 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged â¿¥65 Years - IVY Network, 18 States, September 8-November 30, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36505949 | Clinical and occupational risk factors for coronavirus disease 2019 (COVID-19) in healthcare personnel. | Antimicrob Steward Healthc Epidemiol | 2022 |
| 36568832 | Know your Microbe Foes: The Role of Surveillance in Combatting Antimicrobial Resistance. | Yale J Biol Med | 2022 |
| 36483397 | Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020-April 2021. | Antimicrob Steward Healthc Epidemiol | 2022 |
| 36483363 | Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection. | Antimicrob Steward Healthc Epidemiol | 2022 |
| 36483341 | Longitudinal analysis of risk factors associated with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hemodialysis patients and healthcare personnel in outpatient hemodialysis centers. | Antimicrob Steward Healthc Epidemiol | 2022 |
| 36310813 | Predictors of humoral response to SARS-CoV-2 mRNA vaccine BNT162b2 in patients receiving maintenance dialysis. | Antimicrob Steward Healthc Epidemiol | 2022 |
| 36175202 | Assessment of dental health care personnel protocol deviations and self-contamination during personal protective equipment donning and doffing. | J Am Dent Assoc | 2022 |
| 36264830 | Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36254518 | Dissemination and implementation science and antimicrobial stewardship in solid organ transplantation: A perspective. | Transpl Infect Dis | 2022 |
| 36220174 | Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. | BMJ | 2022 |
| 36374708 | Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States. | Vaccine | 2022 |
| 33487199 | Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology. | Infect Control Hosp Epidemiol | 2022 |
| 35186791 | Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results. | Front Cell Infect Microbiol | 2022 |
| 35085218 | Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34932114 | Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021. | J Infect Dis | 2022 |
| 35264324 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. | BMJ | 2022 |